Primary Intracranial Spindle Cell Sarcoma, DICER1-Mutant, with MDM2 Amplification Diagnosed on the Basis of Extensive Molecular Profiling
Open Access
- 17 October 2022
- journal article
- research article
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 15
Abstract
Primary intracranial spindle cell sarcoma is an extremely rare mesenchymal tumor, the molecular pathogenesis of which is poorly understood. Because of the lack of specific markers, diagnosis sometimes relies on ruling out all possible differential diagnoses, often making it difficult to reach a definitive diagnosis. In this case study, we report a 69 year-old female patient for whom the integration of multi-layered molecular analyses contributed to making the diagnosis. The disease exhibited aggressive clinical behavior, requiring two sequential surgeries because of rapid regrowth within a short period. Primary and recurrent tumors exhibited similar histological features, in which spindle-shaped cells arranged in interlacing fascicles without any specific architectures, implicating sarcomatous tumors. In immunohistochemistry testing, tumor cells were immunopositive for vimentin but lacked any specific findings that contribute to narrowing down the differential diagnoses. Seeking further diagnostic clues, we performed DNA methylation-based analysis. The copy number analysis revealed MDM2 gene amplification and loss of heterozygosity of 22q. Moreover, dimension reduction clustering analysis implicated a methylation pattern comparable to aggressive types of sarcomas. In addition, an in-house next-generation sequencing panel (“Todai-OncoPanel”) analysis identified somatic mutations in DICER1, NF2, and ATRX genes. Taken all together, we finally made the diagnosis of primary intracranial spindle cell sarcoma, DICER1-mutant, with MDM2 gene amplification. This case report suggests that even for the tumors with insufficient morphological and immuno-histological diagnostic clues, integration of multi-layered molecular analyses can contribute to making the diagnoses as well as to understanding the rare tumors by elucidating unexpected genetic and epigenetic features.Keywords
This publication has 25 references indexed in Scilit:
- Genetic and epigenetic stability of oligodendrogliomas at recurrenceActa Neuropathologica Communications, 2017
- COSMIC: somatic cancer genetics at high-resolutionNucleic Acids Research, 2016
- Epileptic seizure in primary intracranial sarcoma: a case report and literature reviewChild's Nervous System, 2016
- Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in childrenJournal of neurosurgery. Pediatrics, 2016
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)The Journal of Molecular Diagnostics, 2015
- Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinomaNature Genetics, 2014
- Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groupsJournal of Neuro-Oncology, 2012
- Exploring the “two‐hit hypothesis” in NF2: Tests of two‐hit and three‐hit models of vestibular schwannoma developmentGenetic Epidemiology, 2003
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- Combined Irradiation and Chemotherapy Using Ifosfamide, Cisplatin, and Etoposide for Children with Medulloblastoma/Posterior Fossa Primitive Neuroectodermal Tumor —Results of a Pilot Study—Neurologia medico-chirurgica, 1996